Molecular Parasitology Lab., Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India.
Nuclear Signalling Lab., Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Monash, VIC 3800, Australia.
Int J Mol Sci. 2022 Nov 11;23(22):13899. doi: 10.3390/ijms232213899.
Signal-dependent transport into and out of the nucleus mediated by members of the importin (IMP) superfamily of nuclear transporters is critical to the eukaryotic function and a point of therapeutic intervention with the potential to limit disease progression and pathogenic outcomes. Although the apicomplexan parasites and both retain unique IMPα genes that are essential, a detailed analysis of their properties has not been performed. As a first step to validate apicomplexan IMPα as a target, we set out to compare the properties of and IMPα (PfIMPα and TgIMPα, respectively) to those of mammalian IMPα, as exemplified by IMPα (MmIMPα). Close similarities were evident, with all three showing high-affinity binding to modular nuclear localisation signals (NLSs) from apicomplexans as well as Simian virus SV40 large tumour antigen (T-ag). PfIMPα and TgIMPα were also capable of binding to mammalian IMPβ1 (MmIMPβ1) with high affinity; strikingly, NLS binding by PfIMPα and TgIMPα could be inhibited by the mammalian IMPα targeting small molecules ivermectin and GW5074 through direct binding to PfIMPα and TgIMPα to perturb the α-helical structure. Importantly, GW5074 could be shown for the first time to resemble ivermectin in being able to limit growth of . The results confirm apicomplexan IMPα as a viable target for the development of therapeutics, with agents targeting it worthy of further consideration as an antimalarial.
信号依赖性核输入和输出是由核转运蛋白的导入蛋白(IMP)超家族成员介导的,这对真核生物的功能至关重要,也是治疗干预的一个切入点,有可能限制疾病的进展和致病后果。尽管 和 这两种顶复门寄生虫都保留了独特的、必不可少的 IMPα 基因,但对它们的特性尚未进行详细分析。作为验证顶复门 IMPα 作为靶标的第一步,我们着手比较 和 IMPα(分别为 PfIMPα 和 TgIMPα)与哺乳动物 IMPα(以 IMPα 为例,MmIMPα)的特性。显然,所有三种 IMPα 都具有高度相似性,均能与来自顶复门的模块化核定位信号(NLS)以及猴病毒 SV40 大肿瘤抗原(T-ag)高亲和力结合。PfIMPα 和 TgIMPα 也能够与哺乳动物 IMPβ1(MmIMPβ1)高亲和力结合;引人注目的是,PfIMPα 和 TgIMPα 的 NLS 结合可被哺乳动物 IMPα 靶向小分子伊维菌素和 GW5074 抑制,通过直接与 PfIMPα 和 TgIMPα 结合来扰乱 α-螺旋结构。重要的是,GW5074 首次被证明类似于伊维菌素,能够限制 的生长。研究结果证实,顶复门 IMPα 是开发治疗药物的可行靶标,靶向该蛋白的药物值得进一步考虑作为抗疟药物。